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Introduction
For more than decades, conventional invasive coronary angiography has been the gold standard for the diagnosis of coronary artery disease and clinical decision making for percutaneous coronary intervention (PCI). However, coronary angiography has several limitations, including the substantial interpretation variability of visual estimates and assessment of lesion severity for diffuse atherosclerotic lesions and intermediate-severity lesions. 1, 2) The recent improvement of technical aspects of multimodality coronary imaging allow not only assessment of the degree of vessel luminal narrowing but also evaluation of the plaque characteristics and the useful prognostic information and accurate risk stratification. Among them coronary angioscopy is the coronary imaging modality that enables direct visualization of internal surface of a vessel. Moreover it provides the detail information of plaque morphology or thrombus formation. 3, 4) A lot of previous studies have shown that coronary angioscopy enabled not only the detection of vulnerable plaque but also prediction of cardiovascular events and percutaneous coronary intervention related complications.
In this review, we discuss the role of coronary angioscopy for coronary plaque imaging, including in a comparison with other currently available imaging modalities used to examine atherosclerotic plaque.
Coronary Angioscopy
Coronary angioscopy enables direct visualization of internal surface of a vessel and provides the detail information of various plaque morphology or thrombus formation. 3, 4) Coronary plaques are assessed based on the surface color and characteristics.
Plaque color is classified as white, light yellow, yellow (medium yellow) or intensive yellow (dark yellow) 4, 5) (Fig. 1A ). Yellow plaques of higher color grade is strongly related with the positive remodeling, thrombus formation and thin-cap fibroatheroma (TCFA) and considered high-risk plaque, [5] [6] [7] [8] whereas white plaques correlate fibrous plaque or pathological intimal thickening and is considered as stable plaque. 9) Coronary angioscopy also has the ability to visualize intraluminal thrombus for high sensitivity and specificity, 10) and angioscopic thrombus is classified as red, white or mixed thrombus 11) (Fig. 1B) . Furthermore this modality allows evaluation of neointimal coverage (NIC) after stent implantation and NIC was classified into 3 or 4 grades 12, 13) (Fig. 1C) . In particular coronary angioscopy was the first imaging modality that enabled direct visualization of neoatherosclerosis after drug-eluting stent (DES) implantation. NIC at 1 year after 2nd-generation DES implantation was more homogeneous with white and less thrombus than that after 1st-generation DES. 13) Another study showed in-stent yellow plaque at 1 year after DES implantation was associated with cardiovascular event. 15) According to the reports of histopathologic validation of coronary angioscopy, yellow plaque had a thinner fibrous cap and a larger lipid core area compared to the white plaque. 16 Another VH-IVUS analysis showed that the amount of necrotic core was significantly larger in Grade 2 and Grade 3 yellow plaque than white plaque 35) (Fig. 2) . IB-IVUS analysis revealed that the surface color of plaques in coronary angioscopy reflected the thickness of the fibrous cap rather than the size of the lipid core. 30) However, VH-IVUS or IB-IVUS have some limitations in assessing thrombus compared to coronary angioscopy because they can't detect thrombus precisely. Therefore, they may not sufficiently evaluate plaque morphology in ACS.
Optical coherence tomography (OCT)
Optical coherence tomography (OCT) is a high-resolution method for imaging plaque characteristics (approximately 10-μm resolution), so it is able to identify precise plaque characterization including fibrous cap thickness, lipid content, raptured plaque, erosion, calcified nodules, and thrombi. 36) In particular OCT-derived TCFA is an important feature of vulnerable plaque. TCFA is characterized by a necrotic core covered by fibrous cap with a thickness < 65 μm, containing rare smooth muscle cells but numerous macrophages, and often increased number of intraplaque vasa vasorum. 37) However OCT has some limitation in evaluating total plaque volume or vessel remodel- demonstrates that macrophage infiltration was more frequent in ACS patients than in non-ACS patients (82.4% vs. 37.9%).
45)
The presence of microchannel formation 46) and cholesterol crystal 47, 48) are also known to be markers of plaque vulnerability, which are detectable in OCT.
Fig. 3A In the angioscopic images, plaque color was graded as white (A-1), light yellow (B-1), yellow (C-1), or intensive yellow (D-1). A lipid pool (*) was characterized by a signal-poor region, and it was semiquantified as the number of involved quadrants on the cross-sectional OCT image (A-2, B-2, C-2, D-2).
The fibrous cap was identified as a signal-rich region between the coronary artery lumen and inner border of lipid pool in the OCT image, and its thickness was measured at the thinnest part (A-3, B-3, C-3, D-3; arrows). OCT: optical coherence tomography.
Reprinted with permission from Kubo T, et al.
6)

Fig. 3B
There was a significant negative correlation between yellow color intensity and fibrous cap thickness. Reprinted with permission from Kubo T, et al.
6)
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Computed tomography (CT)
Coronary computed tomography angiography (CCTA) is a promising technique for non-invasive coronary angiography.
With the improvement in the technical aspects of CCTA, it is possible not only to detect coronary artery stenosis but also to evaluate plaque characteristics including identification of the vulnerable plaque. 
Magnetic resonance imaging (MRI)
Recently non-contrast T1-wieghted imaging (T1W1) has emerged as a novel non-invasive imaging modality when searching for vulnerable coronary plaque and high intensity plaque (HIP) detected on non-contrast T1WI has been considered to be vulnerable coronary plaque. [59] [60] [61] [62] [63] HIP was defined as plaque with higher plaque to myocardium signal intensity ratio (PMR), 59) which was calculated as the signal intensity of the cor- 
Prediction of Cardiovascular Event by Coronary Angioscopy
Prediction of progression to ACS or occurrence of cardiovascular event (CVE)
In prospective follow-up study in 157 patients with SAP observed by coronary angioscopy, acute coronary syndromes were occurred more frequently in patients with glistening yellow plaques than in those without glistening yellow plaques. 64) Another prospective study, which followed 552 patients who received catheterization and angioscopic examination for the diagnosis of coronary artery disease, showed that patients with multiple yellow plaques have higher risk of suffering ACS than that without yellow plaque. 65) Ueda et al. demonstrated in the DES-NOTE study that coronary angioscopy-verified in-stent yellow plaque at 1 year after DES implantation was associated with cardiovascular event (CVE) defined as cardiac death, myocardial infarction, unstable angina, or target lesion revascularization.
15)
The incidence of CVE was significantly higher in the patients with yellow plaque than in those without yellow plaque during the periods of 1558 ± 890 days (8.1% vs 1.6%, P = 0.02), and the presence of in-stent yellow plaque was revealed as a predictor of CVE. Furthermore recent study, which investigated the relationship between the degree of atherosclerotic changes in the descending thoracic aorta and the coronary artery using coronary angioscopy, showed the angioscopic progression of aortic atherosclerosis is closely associated with vulnerability to and the extent of coronary stenosis. 
Prediction of PMI
In patients with non-ST-elevated-ACS who underwent pre-interventional coronary angioscopy at the culprit lesions, the presence of coronary angiography derived thrombus was to be the only independent factor associated with elevated troponin T levels before catheterization. 67 
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